IPO Calendar
Lead Manager
- J P Morgan Chase (490)
- Goldman Sachs (463)
- Morgan Stanley (421)
- Bank of America Merrill Lynch (358)
- Citigroup (222)
- Jefferies (214)
- Credit Suisse (180)
- Barclays (151)
- Cowen and Company (147)
- Deutsche Bank (84)
- Piper Jaffray (70)
- Leerink Partners (70)
- Stifel (65)
- UBS Investment Bank (53)
- Evercore (52)
- RBC Capital (51)
- BMO Capital (49)
- Wells Fargo (47)
- Raymond James (38)
- William Blair (37)
More +
IPO - Pricing (8)
Piper Jaffray
| UnderWriters* | |||||||||||
| Date | Company Name | Sector | Price ($) |
Size (M) |
1 | 2 | 3 | Rank | Turnover | Gain | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 20 | Ventyx Bioscien | Health-Care | 16 | 9 | JEFF | EVCR | PPRJ | 17.9% | 31.4% | ||
| Oct 15 | Paragon 28 Inc. | Health-Care | 16 | 7 | BAML | PPRJ | 55.7% | 13.6% | |||
| Jul 29 | Nuvalent Inc. | Health-Care | 17 | 9 | JPM | COWN | PPRJ | 23.9% | 10.3% | ||
| Jul 23 | Cytek BioScienc | Health-Care | 17 | 16 | MS | GS | PPRJ | 18.9% | 10.4% | ||
| Mar 19 | Connect Biophar | Health-Care | 17 | 11 | JEFF | PPRJ | CICC | 28.4% | 8.8% | ||
| Mar 4 | Khosla Ventures | Finance | 10 | 30 | GS | PPRJ | 28.1% | 2.5% | |||
| Feb 12 | Talis Biomedica | Health-Care | 16 | 13 | JPM | BAML | PPRJ | 22.8% | 73.8% | ||
| Feb 4 | Sensei Biothera | Health-Care | 19 | 7 | CITI | PPRJ | OPPN | 52.7% | -0.5% | ||
*
Lead manager or one of top three managers in an underwriting team.